RecruitingNot applicableNCT05992532

GammaGA: Prevalence of Acid Sphingomyelinase Deficiency Disease (ASMD) and Gaucher Disease in Patients With Monoclonal Gammopathies and/or Multiple Myeloma

Studying Gaucher disease

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Fundación Española de Hematología y Hemoterapía
Principal Investigator: FEHH SEHH, MD
Enrollment: 210 enrolled
Eligibility: 18-99 years · All sexes
Timeline: 2023 – 2025

Study locations (20)

Hospital Universitario de Álava, Vitoria-Gasteiz, Alava, Spain
Hospital Universitario Torrecárdenas, Almería, Almería, Spain
Hospital Son Espases, Palma de Mallorca, Balearic Islands, Spain
Hospital Parc Taulí, Sabadell, Barcelona, Spain
Hospital Universitario de Burgos, Burgos, Burgos, Spain
Hospital de Valdepeñas, Valdepeñas, Ciudad Real, Spain
Hospital Universitario Dr. Josep Trueta, Girona, Girona, Spain
Hospital Universitario Virgen de las Nieves, Granada, Granada, Spain
Hospital San Jorge, Huesca, Huesca, Spain
Hospital de Jaén, Jaén, Jaén, Spain
Hospital del Bierzo, Ponferrada, León, Spain
Hospital Arnau de Vilanova, Lleida, Lleida, Spain
Hospital Universitario La Paz, Madrid, Madrid, Spain
Hospital Universitario Ramón y Cajal, Madrid, Madrid, Spain
Hospital Fundación Jiménez Díaz, Madrid, Madrid, Spain
+5 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05992532 on ClinicalTrials.gov

Other trials for Gaucher disease

Additional recruiting or active studies for the same condition.

See all trials for Gaucher disease →

← Back to all trials